Temporally ordered associations between type 2 diabetes and brain disorders – a Danish register-based cohort study

Abstract

Background Type 2 diabetes mellitus (T2DM) is linked with several neurodegenerative and psychiatric disorders, either as a comorbid condition or as a risk factor. We aimed to expand the evidence by examining associations with a broad range of brain disorders (psychiatric and neurological disorders, excluding late-onset neurodegenerative disorders), while also accounting for the temporal order of T2DM and these brain disorders. Methods In a population-based cohort-study of 1,883,198 Danish citizens, born 1955–1984 and followed until end of 2016, we estimated associations between T2DM and 16 brain disorders first diagnosed between childhood and mid-adulthood. We calculated odds ratios (OR) and hazard ratios (HR) with 95% confidence intervals (CI) in temporally ordered analyses (brain disorder diagnosis after T2DM and vice versa), adjusted for sex, age, follow-up, birth year, and parental factors. Results A total of 67,660 (3.6%) of the study population were identified as T2DM cases after age 30 and by a mean age of 45 years (SD of 8 years). T2DM was associated with most psychiatric disorders. Strongest associations were seen with other (i.e. non-anorectic) eating disorders (OR [95% CI]: 2.64 [2.36–2.94]) and schizophrenia spectrum disorder (2.73 [2.63–2.84]). Among neurological disorders especially inflammatory brain diseases (1.73 [1.57–1.91]) and epilepsy (1.67 [1.60–1.75]) were associated with T2DM. Most associations remained in both directions in the temporally ordered analyses. For most psychiatric disorders, associations were strongest in females. Conclusions T2DM was associated with several psychiatric and neurological disorders, and most associations were consistently found for both temporal order of disorders. This suggests a shared etiology of T2DM and those brain disorders. This study can form the starting point for studies directed at further elucidating potential causal links between disorders and shared biological mechanisms.

Psychiatric traits and intracerebral hemorrhage: A Mendelian randomization study

“…A meta-analysis suggested a higher incidence and mortality from cardiocerebral vascular disease in people with severe mental illness than in those without ( 37 ). Some mental illnesses are associated with insulin resistance ( 38 , 39 ); patients with severe mental illness are more likely to develop diabetes with more severe and frequent microvascular and macrovascular complications, and insulin resistance may further contribute to hypertension, thereby increasing the risk of cardiocerebral vascular disease ( 40 ). In addition, a recent MR study suggested that mood swings are related to cardiocerebral vascular disease risk ( 41 ).…”

Local patterns of genetic sharing challenge the boundaries between neuropsychiatric and insulin resistance-related conditions

“…Multimorbidity, defined as the co-occurrence of multiple conditions within an individual, poses substantial challenges to healthcare systems (Skou et al, 2022). An example is the observed co-occurrence of insulin resistance (IR)-related metabolic conditions, such as type 2 diabetes mellitus (T2DM), obesity, and metabolic syndrome (MetS), with neuropsychiatric disorders (Wimberley et al, 2022). This multimorbidity contributes to more severe physical and mental health outcomes, leading to reduced treatment effectiveness and higher mortality rates (Fanelli and Serretti, 2022; Kraus et al, 2023; Possidente et al, 2023).…”

Treatment Resistance in Schizophrenia Is Associated with Attention Deficit/Hyperactivity Disorder and Gut Microbiota: A Genetic Correlation and Mendelian Randomization Study

“…Stratified analyses showed negative genetic covariances between schizophrenia and somatic insulinopathies through gene sets related to insulin signaling and insulin receptor recycling [14]. Strongest associations were confirmed between type 2 diabetes mellitus and schizophrenia spectrum disorder [15]. A cross-sectional study has shown differences in the composition of the gut microbiota between healthy individuals and patients with schizophrenia [16].…”